Literature DB >> 28535982

Altered gene expression in early postnatal monoamine oxidase A knockout mice.

Kevin Chen1, Abbey Kardys1, Yibu Chen2, Stephen Flink3, Boris Tabakoff3, Jean C Shih4.   

Abstract

We reported previously that monoamine oxidase (MAO) A knockout (KO) mice show increased serotonin (5-hydroxytryptamine, 5-HT) levels and autistic-like behaviors characterized by repetitive behaviors, and anti-social behaviors. We showed that administration of the serotonin synthesis inhibitor para-chlorophenylalanine (pCPA) from post-natal day 1 (P1) through 7 (P7) in MAO A KO mice reduced the serotonin level to normal and reverses the repetitive behavior. These results suggested that the altered gene expression at P1 and P7 may be important for the autistic-like behaviors seen in MAO A KO mice and was studied here. In this study, Affymetrix mRNA array data for P1 and P7 MAO A KO mice were analyzed using Partek Genomics Suite and Ingenuity Pathways Analysis to identify genes differentially expressed versus wild-type and assess their functions and relationships. The number of significant differentially expressed genes (DEGs) varied with age: P1 (664) and P7 (3307) [false discovery rate (FDR) <0.05, fold-change (FC) >1.5 for autism-linked genes and >2.0 for functionally categorized genes]. Eight autism-linked genes were differentially expressed in P1 (upregulated: NLGN3, SLC6A2; down-regulated: HTR2C, MET, ADSL, MECP2, ALDH5A1, GRIN3B) while four autism-linked genes were differentially expressed at P7 (upregulated: HTR2B; downregulated: GRIN2D, GRIN2B, CHRNA4). Many other genes involved in neurodevelopment, apoptosis, neurotransmission, and cognitive function were differentially expressed at P7 in MAO A KO mice. This result suggests that modulation of these genes by the increased serotonin may lead to neurodevelopmental alteration in MAO A KO mice and results in autistic-like behaviors.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Autism; Brain; Development; Monoamine oxidase; Serotonin

Mesh:

Substances:

Year:  2017        PMID: 28535982      PMCID: PMC5531263          DOI: 10.1016/j.brainres.2017.05.017

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  57 in total

1.  Meta-Analysis of Gene Expression in Autism Spectrum Disorder.

Authors:  Carolyn Ch'ng; Willie Kwok; Sanja Rogic; Paul Pavlidis
Journal:  Autism Res       Date:  2015-02-26       Impact factor: 5.216

2.  Serotonin transport and serotonin transporter-mediated antidepressant recognition are controlled by 5-HT2B receptor signaling in serotonergic neuronal cells.

Authors:  Jean-Marie Launay; Benoit Schneider; Sylvain Loric; Mose Da Prada; Odile Kellermann
Journal:  FASEB J       Date:  2006-09       Impact factor: 5.191

3.  Common variants in genes of the postsynaptic FMRP signalling pathway are risk factors for autism spectrum disorders.

Authors:  Regina Waltes; Eftichia Duketis; Michael Knapp; Richard J L Anney; Guillaume Huguet; Sabine Schlitt; Tomasz A Jarczok; Michael Sachse; Laura M Kämpfer; Tina Kleinböck; Fritz Poustka; Sven Bölte; Gabriele Schmötzer; Anette Voran; Ellen Huy; Jobst Meyer; Thomas Bourgeron; Sabine M Klauck; Christine M Freitag; Andreas G Chiocchetti
Journal:  Hum Genet       Date:  2014-01-19       Impact factor: 4.132

4.  Cerebral lobes in autism: early hyperplasia and abnormal age effects.

Authors:  Ruth A Carper; Pamela Moses; Zachary D Tigue; Eric Courchesne
Journal:  Neuroimage       Date:  2002-08       Impact factor: 6.556

5.  Autism-associated neuroligin-3 mutations commonly impair striatal circuits to boost repetitive behaviors.

Authors:  Patrick E Rothwell; Marc V Fuccillo; Stephan Maxeiner; Scott J Hayton; Ozgun Gokce; Byung Kook Lim; Stephen C Fowler; Robert C Malenka; Thomas C Südhof
Journal:  Cell       Date:  2014-07-03       Impact factor: 41.582

Review 6.  Monoamine oxidase: from genes to behavior.

Authors:  J C Shih; K Chen; M J Ridd
Journal:  Annu Rev Neurosci       Date:  1999       Impact factor: 12.449

7.  Early postnatal inhibition of serotonin synthesis results in long-term reductions of perseverative behaviors, but not aggression, in MAO A-deficient mice.

Authors:  Marco Bortolato; Sean C Godar; Simone Tambaro; Felix G Li; Paola Devoto; Marcelo P Coba; Kevin Chen; Jean C Shih
Journal:  Neuropharmacology       Date:  2013-07-16       Impact factor: 5.250

8.  Novel monoamine oxidase A knock out mice with human-like spontaneous mutation.

Authors:  Anna L Scott; Marco Bortolato; Kevin Chen; Jean C Shih
Journal:  Neuroreport       Date:  2008-05-07       Impact factor: 1.837

Review 9.  Monoamine oxidase inactivation: from pathophysiology to therapeutics.

Authors:  Marco Bortolato; Kevin Chen; Jean C Shih
Journal:  Adv Drug Deliv Rev       Date:  2008-07-04       Impact factor: 15.470

10.  Using Gene Ontology to describe the role of the neurexin-neuroligin-SHANK complex in human, mouse and rat and its relevance to autism.

Authors:  Sejal Patel; Paola Roncaglia; Ruth C Lovering
Journal:  BMC Bioinformatics       Date:  2015-06-06       Impact factor: 3.169

View more
  2 in total

Review 1.  Emerging evidence implicating a role for neurexins in neurodegenerative and neuropsychiatric disorders.

Authors:  Katelyn Cuttler; Maryam Hassan; Jonathan Carr; Ruben Cloete; Soraya Bardien
Journal:  Open Biol       Date:  2021-10-06       Impact factor: 6.411

2.  Perinatal MAO Inhibition Produces Long-Lasting Impairment of Serotonin Function in Offspring.

Authors:  Mark W Burke; Myriam Fillion; Jose Mejia; Frank R Ervin; Roberta M Palmour
Journal:  Brain Sci       Date:  2018-06-11
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.